---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-026883"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2025-12-09T23:59:59+00:00"
generated_at: "2026-05-16T13:54:11.019300+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oncotelic closes initial 11 units of up to 500-unit offering with 12% notes and warrants

## Summary
- Initial closing of 11 units at $25,000 each in best-efforts offering of up to 500 units.
- Each unit includes a $25,000 note bearing 12% annual interest, due 2 years after final closing.
- Notes convertible into OTLC common at $0.10/share or EdgePoint AI common at $1.00/share.
- Each unit includes 250,000 warrants to buy OTLC common at $0.12/share or 25,000 EdgePoint warrants at $1.25/share.
- Minimum of 10 units required; funds held in escrow until minimum met; offering exempt under Reg D Rule 506.

## SEC filing metadata
- accession: 0001493152-25-026883
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2025-12-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315225026883/0001493152-25-026883-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315225026883/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-026883
- JSON: https://secwatch.observer/filing/0001493152-25-026883.json
- Plain text: https://secwatch.observer/filing/0001493152-25-026883.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.